A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis
Lin Cai(Peking University), Jie Zheng, Gen-Hui Chen(Beijing Tianheng Pharmaceutical Research Institute), Baoxi Wang(Air Force Medical University), Qianjin Lu(Central South University), Xing‐Hua Gao(First Hospital of China Medical University), Furen Zhang(Shandong Provincial Institute of Dermatology and Venereology), Fuqiu Li(Second Affiliated Hospital of Jilin University), Qingshan Zheng(Shanghai University of Traditional Chinese Medicine), Danqi Deng(Kunming Medical University), Hong Fang(Arkansas State University), Qiuning Sun(Anhui Medical University), Sen Yang, Hongxia Liu(Shanghai University of Traditional Chinese Medicine), Min Zheng(Second Affiliated Hospital of Zhejiang University), Jin Chen(University of Electronic Science and Technology of China), Ruoyu Li(Hefei University of Technology), Yuzhen Li(Harbin Medical University), Fei Hao(Suzhou Institute of Nano-tech and Nano-bionics), Quanzhong Liu(Tianjin Medical University General Hospital), Jinhua Xu(Fudan University), Tianwen Gao(Xijing Hospital), Jian-Bin Yu(First Affiliated Hospital of Zhengzhou University), Shengxiang Xiao(Second Affiliated Hospital of Xi'an Jiaotong University), Yating Tu(Union Hospital)
Cited by 37
Related Papers
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
|Nature Genetics|2009|951
Demethylation of <i>CD40LG</i> on the Inactive X in T Cells from Women with Lupus
|The Journal of Immunology|2007|466
Induced Regulatory T Cells: Their Development, Stability, and Applications
|Trends in Immunology|2016|451
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
|Clinical Reviews in Allergy & Immunology|2013|372
Association analyses identify six new psoriasis susceptibility loci in the Chinese population
|Nature Genetics|2010|317